Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Huzhou Yihui Biotechnology
Huzhou, Zhejiang, China
- Ownership
- Private
- Development stage
- Other
01
Overview
Since 2009, Huzhou Yihui Biotechnology has developed and industrialized dozens of pharmaceutical intermediate products, notably non-natural amino acids, chiral alcohols, and chiral amines. Through collaboration with the Chinese Academy of Sciences, it has built a large customizable biocatalytic enzyme platform.[1][2]
- Therapeutic areas
- Other
- Modalities
- EnzymeBiocatalyst
- Industry
- Non-Drug Biotech
02
Partnerships
Huzhou Industrial Biotechnology Center of Shanghai Institute of Life Sciences, Chinese Academy of Sciences
Beyond the preview
Go deeper on Huzhou Yihui Biotechnology.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Huzhou Yihui Biotechnology.